Chen Zhao

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial

Jia Liu, Wei Yang, Yue Liu et al. · Phytomedicine · 2021 · 71 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Placebo design in WHO-registered trials of Chinese herbal medicine need improvements

Xuan Zhang, Ran Tian, Chen Zhao et al. · BMC Complementary and Alternative Medicine · 2019 · 57 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +11

Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries

Xuan Zhang, Ran Tian, Zhen Yang et al. · BMJ Open · 2019 · 50 citations · Full text

Pharmacy, Biomedical Informatics, Clinical Data Management +15

Direct modulation of myelin-autoreactive CD4<sup>+</sup> and CD8<sup>+</sup> T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules

Weiya Pei, Xin Wan, Khawar Ali Shahzad et al. · International Journal of Nanomedicine · 2018 · 48 citations · Full text

Life Sciences, Immunology, Pharmaceutics +17

Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement

Xuan Zhang, Ran Tian, Wai Ching Lam et al. · Chinese Medicine · 2020 · 41 citations · Full text

Pharmacy, Health Sciences, Clinical Epidemiology +16